Cite
HARVARD Citation
Olivier, A. et al. (2017). Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS‐HF trial. European journal of heart failure. pp. 1186-1197. [Online].